3B BlackBio Dx (BOM:532067) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 29, 2026)


BOM:532067 3B BlackBio Dx Ltd BOM:532067
63 GF Score
Price ₹1,173.05
GF Value ₹2,097.99
Valuation Possible Value Trap
! 2 Warning Signs
View Full Analysis

What is 3B BlackBio Dx Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

3B BlackBio Dx's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:532067 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, 3B BlackBio Dx's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

3B BlackBio Dx Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's Margin of Safety % (DCF Earnings Based) falls into.


BOM:532067
63GF Score
3B BlackBio Dx Ltd BOM:532067
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is 3B BlackBio Dx (BOM:532067) Overvalued in 2026?

Based on GuruFocus' analysis, 3B BlackBio Dx stock appears to be undervalued. The current stock price of ₹1,173.05 is trading 44.1% below its estimated GF Value™ of ₹2,097.99. GuruFocus considers 3B BlackBio Dx to be Possible Value Trap.

Key valuation signals for BOM:532067:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹2,097.99 vs. price of ₹1,173.05 (44.1% below fair value)
  • GF Score™: 63/100 with 2 warning signs

No single metric tells the full story. See the BOM:532067 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

3B BlackBio Dx Business Description

Address 7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is an Indian company specializing in PCR-based Molecular Diagnostic Kits. The company is involved in designing, developing, manufacturing, and commercializing PCR-based Molecular Diagnostic kits, PCR Enzymes, and PCR Reagents.
63GF Score

Get the complete analysis for BOM:532067

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,173.05
Price
₹2,097.99
GF Value